Walden University

ScholarWorks
Walden Dissertations and Doctoral Studies

Walden Dissertations and Doctoral Studies
Collection

2020

Racial Differences in Hospital Readmission and Reimbursement
Rates for Patients with Congestive Heart Failure
Catherine Talongwa
Walden University

Follow this and additional works at: https://scholarworks.waldenu.edu/dissertations
Part of the Health and Medical Administration Commons, and the Public Health Education and
Promotion Commons
This Dissertation is brought to you for free and open access by the Walden Dissertations and Doctoral Studies
Collection at ScholarWorks. It has been accepted for inclusion in Walden Dissertations and Doctoral Studies by an
authorized administrator of ScholarWorks. For more information, please contact ScholarWorks@waldenu.edu.

Walden University
College of Health Sciences

This is to certify that the doctoral study by

Catherine Talongwa

has been found to be complete and satisfactory in all respects,
and that any and all revisions required by
the review committee have been made.

Review Committee
Dr. Miriam Ross, Committee Chairperson, Health Sciences Faculty
Dr. Cynthia Newell, Committee Member, Health Sciences Faculty
Dr. Jagdish Khubchandani, University Reviewer, Health Sciences Faculty

Chief Academic Officer and Provost
Sue Subocz, Ph.D.

Walden University
February 9, 2020

Abstract
Racial Differences in Hospital Readmission and Reimbursement Rates for Patients with
Congestive Heart Failure
by
Catherine Talongwa

MA/MS, Kelley Graduate School of Management, 2006
BSBA, DeVry University, 2002

Doctoral Study Submitted in Partial Fulfillment
of the Requirements for the Degree of
Doctor of Healthcare Administration

Walden University
February 9, 2020

Abstract
Congestive heart failure (CHF) is associated with a significant economic burden that
includes frequent emergency department visits, hospitalizations, and readmissions. The
purpose of this study was to examine the differences, if any, between hospital
readmission rates and insurance reimbursement rates for non-Hispanic Black and White
CHF patients in California. The theoretical framework was Bandura’s social cognitive
theory. Secondary data for this quantitative study were obtained from the Office of
Statewide Health Planning and Development and State Inpatient Databases from
Healthcare Cost and Utilization for calendar year 2014-2016. A t-test and Levene’s test
for equality of variance were conducted on a sample of 11,905 patient records from 675
hospitals in California; the readmission discharge data and insurance reimbursement rates
were analyzed by ethnicity and payer type. The results indicated that there was not a
statistically significant difference between non-Hispanic Blacks as compared to nonHispanic Whites in relation to readmission rates (M = 49.6, SD = 38.28) or insurance
reimbursement rates (M = 50.88, SD = 36.52). Non-Hispanic Blacks had a higher
readmission rate (36%) as compared to Whites (29%), and although these results are not
significant, they support the need for healthcare professionals to develop programs that
meet the needs of the community. The results of this study contribute to positive social
change by providing information that healthcare professionals may be able to use to
decrease CHF readmissions and improve access to care for non-Hispanic Blacks and
other vulnerable patient groups.
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Section 1: Foundation of the Study and Literature Review
Introduction
Congestive heart failure (CHF) is the most common reason for hospital
readmission among Blacks, non-Hispanic ages 18-64. It is a progressive disease that
afflicts about five million persons in the United States, and African Americans have a
disproportionately high prevalence, especially among young adults (Fonarrow, Konstam,
& Yancy, 2017). According to American Heart Association (2017) statistics, the annual
incidence of heart failure for African Americans is 9.1 per 1,000 per year as compared to
their White counterparts who have a frequency of six incidents per 1,000 per year. As
rehospitalizations continue to increase, reducing hospital readmission rates has become a
significant concern for health care leaders and insurance companies as they seek to
determine the specific causes and the cost burden associated with readmissions for all
patients. The goal of these efforts is to decrease the cost of care, improve outcomes, and
minimize insurance reimbursement penalties (Diaz-Maclnnis, 2018).
Problem Statement
CHF is an escalating health problem in the United States, and the highest cause of
death among Blacks, non-Hispanic (Pandey et al., 2015). Hospital readmission rates for
Blacks continue to increase due to lack of insurance, low reimbursement rates, and
limited access to care (Pandey et al., 2016, p. 938). CHF is associated with a significant
economic burden that includes frequent emergency department visits, hospitalization, and
rehospitalization in Black communities. The rampant nature of CHF readmissions among
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Black patients is due to insurance restrictions or the inability of Black patients to pay for
medical care, according to the U.S. Department of Health and Human Services (2017).
Compared to Whites, non-Hispanic with CHF, Blacks are more likely to be under
age 65 with limited financial resources and a higher level of hospital readmissions
(Pandey et al., 2016). In addition, Black patients have higher uninsured rates than White
patients, which consequently increases hospital readmissions for CHF (Sharma et al.,
2016). The increased clinical and financial burden of this condition, especially among
young and older adults, had led to an interest among hospital administrators in improving
outcomes and decreasing the cost of care (Sharma et al., 2016). Even though there is a
plethora of research on CHF, there is a gap in the literature and a lack of research about
insurance coverage and insurance reimbursement rates associated with readmissions and
differences between non-Hispanic Black and White patients (Levesque, Harris, &
Russell, 2015). I addressed this gap by conducting correlational research.
Purpose of the Study
The purpose of this study was to examine the differences between hospital
readmission and insurance reimbursement rates, if any, for non-Hispanic Blacks and
Whites with CHF in California. Research on the causes of CHF readmissions could
improve health system protocols and enhance access to healthcare by encouraging Black
patients with CHF to follow up with their primary care physician after hospital discharge.
Involving the executive leadership team in the patient readmission process using clear
metrics allows health care administrators to explore necessary adjustments and execute
strategies for setting and achieving patient goals (Wei et al., 2018).
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Access to health care is essential to quality patient care, and, as a result, U.S.
hospital administrators are focusing on efforts to improve the quality of care and reduce
spending on readmissions. The Patient Protection and Affordable Care Act (PPACA) of
2010 has spurred administrators to undertake these efforts (Erdem, Fout, Korda, &
Abolude, 2016). In this study, I used t-test analysis to determine if there were statistically
significant differences between non-Hispanic Black and White CHF patients in relation
to hospital readmission rates, insurance reimbursement rates, and uninsured patients. The
dependent variable for this study was CHF readmission rates for non-Hispanic Black and
White patients in California. The independent variable was insurance reimbursement
rates for non-Hispanic Black and White CHF patients in California. Insurance
reimbursement included an analysis of private insurance, uninsured rates, Medicare, and
Medicaid.
Research Questions and Hypotheses
The research questions (RQs) and hypotheses were as follows:
RQ 1. What is the difference, if any, between hospital CHF readmission rates for
Blacks, non-Hispanic and Whites, non-Hispanic in California?
H11 (Alternative Hypothesis): There is a statistically significant difference
between hospital CHF readmission rates for Blacks, non-Hispanic, and Whites,
non-Hispanic in California.
H01 (Null Hypothesis): There is not a statistically significant difference between
hospital CHF readmission rates for Blacks, non-Hispanic, and Whites, nonHispanic in California.
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RQ 2: What is the difference, if any, between hospital CHF readmission insurance
reimbursement for Blacks, non-Hispanic and Whites, non-Hispanic in California?
H12 (Alternative Hypothesis): There is a statistically significant difference
between hospital CHF readmission insurance reimbursement for Blacks, nonHispanic and Whites, non-Hispanic in California.
H02 (Null Hypothesis): There is not a statistically significant difference between
hospital CHF readmission insurance reimbursement for Blacks, non-Hispanic and
Whites, non-Hispanic in California.
Theoretical Foundation for the Study
The theoretical framework for this study was Bandura’s (1986) social cognitive
theory (SCT). Bandura developed social learning theory in the 1960s and expanded its
key concepts into SCT in 1986 (Bandura, 1986). This theory has been used extensively in
healthcare communication as it pertains to the modeling of behaviors and improvements
in processes (Pajares, Prestin, Chen, & Nabi, 2009). A tenet of SCT is that past
experiences influence reinforcement, expectations, and perceived self-efficacy in patients
(Hoffman, 2016). As such, researchers consider a person’s past experiences and assess
the factors that may lead a person to take a certain action (Hoffman, 2016). SCT
emphasizes that when administrators and staff work together to achieve common goals,
they can make a positive difference in behaviors (Pajares et al., 2009). SCT also provides
a framework for designing, implementing, and evaluating programs, which could be used
to facilitate and improve care for Black, non-Hispanic CHF patients (Jeihooni, Hidarnia,
Kaveh, Hajizadeh, & Askari, 2016). SCT can be used to understand the circumstances in
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which people acquire and maintain specific behavioral patterns while establishing a
process for intervention (Dybowski, Sehner, & Harendza, 2017).
Self-efficacy, as a construct of SCT, influences the effort one puts forth to change
risk behavior and the persistence to continue striving despite barriers and setbacks that
may undermine motivation (Hoffman, 2016). Although self-efficacy is directly related to
health behavior, it also affects health behaviors indirectly through its impact on goals
(Dybowski, Sehner, & Harendza, 2017). The importance of self-efficacy is that it can
influence how people perceive and embrace change. The more healthcare leaders can
educate and promote health outcome improvements, the greater the likelihood CHF
patient perceptions about self-efficacy will produce desirable results (Bandura, 1997,
2001).
Nature of the Study
This study involved secondary analysis of data. I statistically analyzed the
differences of the variables and determined significance by using a t-test and Levene’s
test for equality of variances. The dependent variable for this study was CHF readmission
rates for non-Hispanic Black and White patients in California. The independent variable
was insurance reimbursement rates for non-Hispanic Black and White CHF patients in
California. Insurance reimbursement included an analysis of private insurance, uninsured
rates, Medicare, and Medicaid.
The secondary data collection involved downloading readmission discharge data
from the Office of Statewide Health Planning and Development (OSHPD) for the
calendar years 2014-2016 and State Inpatient Databases (SID) for the calendar years
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2014- 2016 from the Healthcare Cost and Utilization Project (HCUP). Using the provider
report from the Centers for Medicare & Medicaid Services (CMS), I was able to examine
the following explanatory variables: Diagnosis-related group, provider ID, provider zip
code, total discharged, average covered charges, average total reimbursements, average
Medicare reimbursements, average Medicaid reimbursements, average private insurance
reimbursements, average uninsured private pay reimbursements, age (mean), and breakout. The variables for insurance reimbursement were categorized as follows: average
Medicare payment, average Medicaid payment, average private insurance payment, and
average uninsured private payment (HCUP, 2016; OSHPD, 2016). Probability sampling
was used as the sampling strategy for this study.
Literature Search Strategy
To better understand the increasing number of CHF readmissions, I used several
databases to retrieve the most current literature on CHF, readmissions, and utilization
cost. These articles identified CHF as the leading cause of rehospitalization and also
showed that the uninsured with CHF have poorer health outcomes and a higher rate of
hospital readmissions (Whitworth, 2018). Database searches were my primary means of
finding articles related to this study and gaining an understanding of the research
questions’ strengths and weaknesses. The following Walden University databases and
search engines were used to conduct a systematic literature review on adults aged 18-64:
CINAHL Plus, PubMed, Ovid MEDLINE, Medline, Cochrane, ProQuest, and Google
Search. I focused my search on scholarly journals and articles published in English from
2013 to 2018. In addition, I searched for literature on organizational and governmental
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websites, including AHA.com. CDC.gov, HCUP.ca.gov, Ache.net, minority
health.hhs.gov, ahrq.gov, healthypeople.gov, icpsr.umich.edu, and ncbi.nlm.nih.gov. The
key search terms were readmission, Blacks with CHF, heart failure, congestive heart
failure, chronic disease, rehospitalization, and insurance reimbursement.
Literature Review Related to Key Variables and/or Concepts
The purpose of this literature review was to synthesize studies completed by
researchers about hospital readmission rates (dependent variable) for Black, nonHispanic, and Whites, non-Hispanic patients with CHF, and differences with insurance
coverage and insurance reimbursement rates (independent variables). CHF is an ongoing
health problem, and research has shown that it is the leading cause of death in the United
States (Pandey et al., 2016). Mantel (2015) reported that CHF remains the leading cause
of early hospital readmission among adults aged 18-64 within 30 days of the first
hospitalization. Due to the increase in hospital readmission rates, health care spending
continues to rise among all payer types and threatens the health care delivery system if
substantial changes are not made to prevent avoidable readmissions (Blumenthal et al.,
2015). As Islam, O’Connell, and Lakhan (2017) noted, researchers have reviewed
hospital readmissions, chronic disease management, and CHF to establish some of the
contributing factors associated with hospital readmissions. I review some of these factors
in this literature review.
Hospital Readmission Variable
Financial implications. CHF is an escalating health problem in the United States
and the highest cause of death among the racial/ethnic group Blacks, non-Hispanic
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(Fleming, 2018). CHF was responsible for an enormous amount of healthcare burden
and financial struggle in the United States (Mirkin, Enomoto, Caputo, & Hollenbeak,
2017). According to Mirkin et al. (2017), CHF was the most frequent cause of hospital
readmissions in adults aged 18-64. The authors found that there has been an insignificant
amount of consistency in the variables used to predict readmission criteria. Even though
the authors used predictive and statistical methods to analyze readmission risk factors,
they concluded that there is no magical technique to highlight a better readmission tool to
identify those risk factors associated with hospital readmission. As a result, Mirkin et al.
argued that experts had recommended a risk prediction model encompassing not only the
patient’s condition but also the hospital system and provider approach for determining
patients with higher risk.
Bayati et al. (2016) had similar views about the cost-effectiveness of readmissions
that posed a considerable cost burden in the US. The authors stated that rehospitalization
had been a primary contributor to the 10 billion per year deficit in healthcare expenditure
of CHF patients. The authors also found that 47% of the readmissions that occurred
within 30 days in the Veteran Health Administrations Hospital (VA) was a result of
congestive heart failure. Congestive heart failure is an ongoing health problem in the US,
with a financial impact on the overall cost of health care.
Similarly, Boesen, Leal, Sheehan, and Sobolik (2015) noted that societal and
healthcare issues are predictors of financial implications for readmission. The study
found that CHF patients discharged home without proper discharge information have
shown to be a contributing factor for hospital readmissions. Bayati et al. (2016); Boesen,
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Leal, Sheehan, and Sobolik (2015); and Mirkin et al. (2017) stated that, as a result, the
financial implications in the health care system had opened avenues for researchers to use
predictive models to identify CHF patients with the highest risk factor for readmission.
Improper discharge process. There have been studies that examine the discharge
process as a contributing factor of hospital readmissions for Blacks, non-Hispanic CHF
patients. Feltner et al. (2014) surveyed readmissions and discharge processes and found
little evidence that indicated reduced readmissions due to the discharge process for CHF
patients. Also, the researchers found that home visit programs, telemonitoring, and nurseled programs did not reduce the risk of heart failure readmissions. For these reasons,
Feltner et al. concluded that some of their research directed toward hospital readmissions
yielded results without methodological limitations or direction. Therefore, they surmised
that further research is needed to evaluate the improper discharge process and risk
indicators associated with CHF readmission.
Importantly, the increase in hospital readmission rates is causing healthcare
leaders to look for ways to minimize readmissions. Healthcare leaders are employing the
technique of placing patients into observation status instead of admitting them into the
hospital to reduce readmission penalties (Kaiser Family Foundation, 2015).
Unfortunately, observation status creates other problems concerning readiness for
discharge, patient education, and the dilemma that occurs when a nursing home bed is
needed. Therefore the implications of reporting readmissions are changing the healthcare
delivery system, which confuses patients, families, physicians, and hospital staff (Kim,
Mortensen, & Eldridge, 2015).
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In summary, the increase in the financial penalty for having high readmission
rates is creating a sense of urgency within health care systems. Even though preventing
rehospitalization is a complex issue that encourages providers and health care leaders to
engage in new healthcare delivery models to deliver improved patient outcomes and
lower the cost of care. Healthcare leaders are encouraged to develop tools that will
empower patients to protect and improve their health.
Insurance Reimbursement Variable
Reimbursement incentives to reduce readmissions. In response to the health
care cost increases, insurance providers have developed an array of strategies to control
cost for those they insure including transferring cost to their health plan members and
adding an administrative mechanism to identify and discourage inappropriate care by
penalizing hospitals with higher readmission rates (Erdem et al., 2016).
The PPACA began the next significant and recent shift in reimbursement
consideration in health care (Singer, 2017). According to Blumenthal, Abrams, and
Nuzum (2015), the PPACA embraced efforts to move from volume-based fee-for-service
reimbursement towards performance-based, and this impacted many hospitals negatively
due to higher readmission rates which subjected hospitals to financial penalties.
Bosko, Dubow, and Koenig (2016); Bowling, Newman, White, and Wood (2017)
argued that one goal of the PPACA is to ensure access to health care while also
containing costs through cost-shifting to outpatient service provisions. Policies and
legislative principles that led to the implementation of all-payer systems including rate
setting, cost control, equity, access, solvency, and adequate care provision are explored
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throughout the literature (Bosko, Dubow, & Koenig, 2016; Bowling, Newman, White, &
Wood, 2017). Payment strategies and incentives are vital tools for the success of the
PPACA (Gilman et al., 2015). The PPACA includes insurance reimbursement strategies
such as bundled payments, pay-for-performance, and value-based purchasing, which have
been implemented in various states and supported by the federal government.
Reimbursement strategies must reward provider collaboration, patient-focused care, and
high-quality care with financial incentives to address care cost growth (Gilman et al.,
2015). Incentives such as cost-sharing and rewards based on established goal
achievement remain at the forefront of the ACA's strategy to shape provider behaviors to
reduce costs and improve care quality (Bosko et al., 2016). The following sections
provide additional information about these different insurance reimbursement strategies.
Bundled payments. According to CMS (2017), payers will increasingly seek to
move the financial risk of managing patients to providers through strategies such as
bundled payments and capitation. Bundled payments include all fees for a procedure in
one billing process rather than separating them. The bundled payment creates incentives
for hospitals and physician offices to coordinate patient care and reduce duplicative or
unnecessary services while emphasizing the need to minimize hospital readmissions
(CMS, 2018).
According to Sanghavi et al. (2015), providers view the bundled payment
reimbursement strategy as an opportunity to advance from a compliance-driven culture to
one of collaboration among providers and innovation to reduce health care costs and
improve care quality to patients. Valania and Slawsky (2017) suggested that providers
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are incentivized to lower costs through improved care coordination and quality
improvement while focusing on decreased utilization of costly hospital readmissions.
Bowling et al. (2017), on the other hand, stated that some hospitals view bundling as a
way to reduce provider control over practice decisions. Another strategy for cost control
and collaboration incentive is pay-for-performance.
Pay-for-performance: Incentives to decrease hospital readmissions. CMS
(2018) officials have created and implemented a payment model with goals that
emphasize reductions in cost and improvements in quality. This program incentivizes
and rewards hospitals and providers that meet the goals, which include targets for
decreasing readmissions (CMS, 2018). Caveney (2016, p. 265) stated that pay-forperformance reimbursement methods are based on quality, utilization, and patient
satisfaction along the care continuum. High performing organizations and providers are
also rewarded with a high volume and loyal patient base adding to the organization's
financial solvency. Caveney went further to say that this mechanism of payment was
developed by private and public payers to force hospitals to close the gap on higher
readmission rates and improve the quality of care. Financial incentives are a strong
intrinsic motivation for organizations to provide high-quality care, according to CMS
(2015). Therefore, if organizations achieve the CMS pay-for-performance identified
metrics, the organizations receive financial incentives and high levels of patient,
community, and payer trust (Ayanian & Markel, 2016).
Achievement of performance metrics such as decreased hospital readmission rates
– plus high performance on quality care, patient satisfaction, and ranking results
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compared to other hospitals results in the positive market competition by establishing
high and low performers (Bowling, Newman, White, & Wood, 2017). Baicker (2015)
stated that 90% of these have programs are geared toward physician incentives, whereas
only 38% of incentives are geared toward acute care facilities. Another strategy that is
shown to contain cost and improve quality of care while penalizing hospitals for higher
readmissions is value-based purchasing.
Value-based purchasing: Rewards for decreased readmissions. Another CMS
incentive program is Value-Based Purchasing, which is promoted by the PPACA and
rewards providers and hospitals who emphasize value-based care rather than volume care
and quality care rather than quantity care (Jacobson, 2016). As a result, Heidenreich et al.
(2016), indicated that hospitals with fewer readmissions and high-quality outcomes are
eligible to receive financial rewards. The United States Department of Health and
Human Services (DHHS) (2011a) reported that an estimated 850 million dollars were
earmarked for hospitals achieving star ratings due to established goals on performance
measures, clinical indicators, and patient satisfaction. Jacobson (2016) indicated that
value-based purchasing approaches include service integration, payment strategies, and
value-based insurance design are emphasized in national health care reform legislation.
Uninsured variable, a contributing factor to hospital readmissions. The
comprehensive research conducted by Elixhauser and Steiner (2016) highlighted allpayer, all-cause hospital readmissions. The authors found that most readmissions are the
result of chronic conditions and uninsured patients with limited access to healthcare. CHF
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is known to be one of the highest common chronic diseases that result in patients
readmission within eight to thirty days.
Boesen, Leal, Sheehan, and Sobolik (2015) had similar findings of the causes of
readmissions and revealed that due to the complexities of hospital readmissions, all areas
of a health care system must be targeted. The authors also indicated that creating a
healthcare communications system and looking for ways to connect the uninsured with
insurance will reduce all-causes of readmissions. Similarly, Wang, Shi, Nie, and Zhu
(2015) found that uninsured adults were less likely to obtain preventive care and keep
their physician appointments. Furthermore, the uninsured population was significantly
more likely to have no primary care physician and had difficulties getting attention. The
authors also indicated that blacks with CHF reported an inability to get medical care
through the typical health care delivery system. As a result, they sought treatment in the
emergency room. Also, they suggested that uninsured patients lacked access to care –
both preventive services and treatments - even though studies have shown that uninsured
patients, on average, received 55% of medical services (Wang et al., 2015).
Wang et al. (2015) also stated that income and socioeconomic factors were found
to be a significant contributor to readmissions. Their research results suggested that even
though there were other contributing factors, a lack of insurance was found to be the most
critical factor associated with significant readmissions. The authors indicated that one of
the main goals of the PPACA is to promote universal health coverage by expanding the
State Health Insurance Exchange marketplace. Research has shown that even with the
expansion of the Medi-Cal program in California, ethnicity, socioeconomic status, and
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place of residence are predictors of readmission risk and readmissions (Betancourt, TanMcGrory, & Kenst, 2015). Research indicates that uninsured patients with CHF have a
higher risk of hospital readmission. Boesen, Lead, Sheehan, and Sobolik (2015);
Elixhauser and Steiner (2016) agreed that because CHF is the number one cause of
hospital readmission in the U.S, more research is needed to develop a better delivery
model that will improve access to care, improve patient’s outcome, and lower cost.
Uninsured patients and CHF. Heart failure patients, especially Blacks, nonHispanic, have high rates of hospital readmission (Sharma, Colvin-Adams, & Yancy,
2016). The authors stated in 40,000 patients with heart failure that education, lowerincome, and lack of insurance were significant predictors of hospital readmission. These
socioeconomic factors could account for the delay of inadequate access to health care and
noncompliance with follow-up appointments. The study points to sociodemographic
factors such as sex, age, race/ethnicity, and insurance. As a result, studies have shown
that an increased risk of hospital readmission rates is associated with sociodemographic
factors. Even though Kirby and Kaneda (2016) argued that current research offers a
limited description of the complex health coverage and hospital readmission, especially
for Blacks, non-Hispanic in the United States, the individuals in these health categories
are more likely to require medical care than their white counterpart. The insurance gap
between white and black is more severe than indicated in previous surveys (Noori et al.,
2015).
Furthermore, Kirby and Kaneda (2017) stated that research does not provide
adequate information about the uninsured population, even though many adults aged 18-
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64 do not have access to health care or employer-sponsored programs. Healthcare leaders
are focusing on driving the patchwork of public programs that are available to educate
these populations rather than providing a long-term solution.
Conversely, Martinez et al. (2015) stated that even though adults aged 18-64
could still buy private health insurance plans through the Insurance Marketplace or statebased exchanges as part of the Affordable Care Art of 2010, low-income and
socioeconomic factors highlight unplanned hospital-based care among younger patients.
Black and Schiller (2016) mentioned that the utilization measures among adults aged 1864 who are uninsured with CHF differ from state to state. Kim, Mortensen, and Eldridge
(2015) similarly argued that to link low-income uninsured patients with primary care
physicians who could reduce emergency or hospital readmissions is problematic because
most physicians request payment at the time services are provided.
A study conducted by Clarks and Schiller (2016) found that adults ages 18-64
without health insurance coverage neglect seeking healthcare services. The study showed
that even though the percentage of uninsured adults at the time of the interview decreased
from 16.0% in 2010 to 9.0% in 2016, readmissions for CHF remained significant at state
and federal levels. Ayanian et al. (2015) conducted a similar study on readmissions. This
study showed compelling evidence of the adverse clinical consequences of being
uninsured. Furthermore, the study also examined the type of care received by uninsured
patients with CHF and chronic conditions. The authors found that the quality of care
received by uninsured adults with a low income was substandard and substantially worse
when compared to insured low-income adults, thereby increasing the risk for
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rehospitalization. Even though the government has begun to extend affordable health
insurance to the uninsured, Ayanian et al. (2015) argues that the unmet health needs of 33
million uninsured adults continue to fester in the health care delivery system without a
cohesive political response to minimize avoidable readmissions.
Causes for hospital readmission. Congestive heart failure is a debilitating
condition associated with frequent readmissions. A considerable amount of research has
revealed that 25-60% of readmissions occur within six months of discharge, and these
readmissions are due to a variety of reasons. Noori et al. (2015) concluded there is a
correlation between socioeconomic factors and CHF, which include income and
education as primary risk factors for rehospitalization due to CHF. Also, Noori et al.
identified that these variables - lower educational level, lower-income, and lower job
levels - were shown to cause higher readmission rates even though other variables such as
inadequate physical activity and hypertension were also found to be independent
predictors for readmission. Martsolf et al. (2016) found that the implication for
readmission and insurance reimbursement policy could be affected in two ways: Firstly,
lower-income and educational levels of patients affect readmission rates for a substantial
proportion of hospitals. The financial impact is enormous, and it could be advantageous
to consider this information as opposed to not adding this information to algorithms that
consider overall risk adjustment for readmissions. Secondly, the study also demonstrated
that most of the hospital readmissions were affected by race/ethnicity and socioeconomic
factors that are consistent with previous studies.
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Also, Heidenreich et al. (2016) indicated that the cost of CHF readmissions is
expensive and will remain a substantial concern for health care providers if better efforts
are not put in place to reduce the number of patients developing CHF. Most importantly,
techniques and strategies to prevent CHF readmissions and improve efficiency are
needed to decrease hospital readmissions. The authors also emphasized that the burden of
CHF hospital readmissions will increase in the next 18 years if the current approach or
delivery system is not improved.
A comprehensive study conducted by Basu, Hanchate, and Bierman (2018)
showed that readmission rates could be affected by different insurance reimbursement
rates. Black CHF patients had the highest risk of readmission compared to white CHF
patients when covered by low reimbursement insurance, such as Med-Cal. Having no
insurance was uniformly associated with a higher rate of readmissions in blacks that may
reflect no access to healthcare or suboptimal outcomes. This study is consistent with
work done by Martsolf et al. (2016). Accordingly, Martsolf et al. found that blacks are
susceptible to hospital readmissions within nine days after being discharged. As a result,
the result of the studies had several strengths, including multilevel framework and statelevel focus on sociodemographic composition, including patients aged 18-64 and aged 65
and older. However, the findings of this study may have some useful implications for
states expanding on Medicaid coverage. In conclusion, further studies should investigate
whether Medicaid expansion minimized the readmission rate for black patients with
CHF.
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To summarize, CHF hospitalizations and readmissions have been reported as
common in black patients due to insurance restrictions or the inability to pay for medical
care (HHS, 2017). Blacks are more likely to be under age 65 with limited financial
resources and poorer health status, increasing the frequency of rehospitalization.
Uninsured CHF patients were much less likely than insured adults to have received
routine checkups during which any health risk might have had a different outcome.
Research Gap
I used a systematic approach to choose studies that fulfilled the research goals of
this correlational study and address the gap concerning healthcare access for nonHispanic Black and White patients with CHF in relation to hospital readmissions. The
chosen studies present comprehensive information about the topics. In particular, this
concerned the strengths of the studies conducted by researchers and whether the results
and conclusions provided a consistent approach to the topics.
Overall, I observed that the chosen studies support the need for more research to
address the gap associated with the causes of healthcare access and to add to the body of
knowledge that could improve wellness and reduce hospital readmissions for Black, nonHispanics. For example, Kim, Mortensen, and Eldrige (2015, p. 798) stated that their
goal was to analyze the efficacy of interventions that address the influx of uninsured CHF
patients to the emergency department by using the CMS collaborative efforts of 2010
with local clinics and hospitals. Their findings were consistent with other research.
Martinez, Ward, and Adams (2015) completed a comparative analysis on
uninsured patients readmitted with CHF from 2013-2014 to see if there were any changes
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for adults aged 18-64. Blacks, non-Hispanic with CHF readmissions decreased from
24% to 17.6% due to the Affordable Care Act that provided access to private health
insurance through the Health Insurance Marketplace. However, medical care for Blacks
did not have any significant changes as compared to non-Hispanic Whites.
Ayanian, Weissman, Schneider, Ginsburg, and Zaslavsky (2015) completed a
study about long-term uninsured patients ages 18-64 with chronic conditions, and results
indicated that these patients encountered barriers to preventive services. These barriers
increased the level of hospital readmissions for patients with CHF. The study variables
are somewhat consistent with this study and focused on sex, age, race/ethnicity, income,
education, and employment.
Conclusion
Black, non-Hispanic patients with CHF, are at a significantly higher risk for
hospital readmissions as compared to their white counterparts (Carnethon et al., 2017).
This high rate of hospital readmissions is causing a financial burden for patients,
hospitals, and healthcare providers. The high rehospitalization rates have prompted many
healthcare leaders and providers to create an adaptive health care delivery system to
provide tools to manage chronic conditions at home to reduce rehospitalization (Sharma
et al., 2016). Hospital Administrators are presented with greater responsibilities to
develop tools and methods to reduce readmissions and also to accurately identify highrisk CHF patients effectively. However, like many such studies mentioned above, Black
patients with CHF have been reported to have the highest number of hospital
readmissions due to insurance restrictions that prevent them from having primary care
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physicians to facilitate preventive care (Bergethon et al., 2017). Attention should be
focused on a patient’s socioeconomic status as discharge plans are developed, which may
enable identification of those at highest risk of readmission. Given the cost and quality
implications of these findings, addressing readmissions while caring for an increasingly
diverse population has become a significant concern for hospital administrators and
health care leaders (Swayne, Duncan, & Ginter, 2017).
Definitions
30-day readmission: An admission to an acute care hospital within 30 days of
discharge from the same or another acute care hospital with risk-standardized
readmission measures, which includes all-cause unplanned readmission (Elixhauser &
Steiner, 2015).
Access to care: The availability of services and barriers to access, utilization, and
outcomes of health needs, materials and cultural settings of diverse groups in society
(Agency for Healthcare Research and Quality, 2015)
Congestive heart failure (CHF): A progressive disease that affects the pumping
power of the heart muscles. CHF also refers to a stage in which fluid builds up around
the heart and causes it to pump inefficiently and get worse over time (Whitworth, 2018).
Coordination of care: Any activity that helps ensure that a patient’s needs and
preferences for health services are met. Coordination of care encompasses information
sharing across interdisciplinary teams to facilitate the appropriate delivery of health care
services (Agency for Healthcare Research and Quality, 2016).
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Rehospitalization: A term that is used interchangeably with readmissions,
meaning a return to an acute care hospital after discharge (Islam et al., 2017).
Socioeconomic status: The social standing or class of an individual or group. It is
often measured as a combination of education, income, and occupation. Examinations of
socioeconomic status often reveal inequities in access to resources, plus issues related to
privilege, power, and control (Noori et al., 2016).
Transition of care: The movement of a patient from one care setting to another
(CMS Incentive Program, 2016).
Assumptions
There were assumptions made for this study; the researchers for OSHPD, the
primary data company, assumed that all self-reported information provided by the
research participants was truthful and reliable. This assumption is taken into
consideration because the consent form delivered to the participants indicated that their
identity was concealed, and OSHPD preserves confidentiality. Furthermore, the
participant's rehospitalization experience and situation were assumed to be quantifiable
and generalizable to similar ethnic groups.
Limitations
The following limitations of this study are (a) the use of small study sample,
whereas a larger sample size is desired to enhance methodology and data analysis options
and more reliable to reflect the population means. (b) The study focused on participants
who utilized English (written and verbal) as their primary language, provision of a
translator and translated materials may have allowed for a more culturally and ethnically
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diverse study sample. (c) The period of the data used for this study was only between
2014, 2015, and 2016. A three-year period may not ensure an adequate sample size. (d)
Since data from only one state was utilized, determining all-cause readmissions limited
generalizability to different patient populations in the US. The data was collected in
California, and other states may have had different results. (e) Further limitations
included the possibility of sampling and coding errors, misclassified variables, and the
difficulty in accurately obtaining readmission data for Blacks, non-Hispanics, and other
ethnicities.
Scope and Delimitations
Generalizability
The generalizability of this study was limited to non-Hispanic Black and White
CHF patients in California. Gender, age, and income were not considered for this study
and were not included in the secondary data. The secondary data was obtained from the
Office of Statewide Health Planning and Development (OSHPD) for the calendar year
2014-2016 and State Inpatient Databases (SID) for the calendar year 2014-2016 from
Healthcare Cost and Utilization Project (HCUP). It was determined that this data met the
qualifications for inclusion in the study. A multiplicity of factors influences patients'
readmissions, the purpose of researching in this field, and trying to control confounding
variables is a complex undertaken.
Internal Validity
For this study, participants were selected with certain characteristics that could
predispose them to have certain outcomes. For example, this study uses CHF as the only
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diagnosis. Access to care and conditions of severity are highly subjective between
patients. Internal validity can be minimized by taking preventive action to adhere closely
to the scope of the study (Trochim, Donnelly, & Arora, 2016, p. 217).
External Validity
The threat of interactive effects of experimental arrangement may arise when
results are generalized beyond the racial groups or social groups not included in this
study. Also, OSHPD, the primary data source for this study, collects data from hospitals
which may use different approaches when identifying the readmission process. This
threat may narrow the characteristics of participants in the study (Creswell, 2009).
The purpose of this study is to examine the differences between hospital
readmission rates and insurance reimbursement rates for non-Hispanic Black and White
patients with CHF. Studies have shown that there may be no significant follow up for
Black patients with their primary care physician after hospital discharge. When
involving the executive leadership team in the patient readmission process, it is necessary
to use clear metrics in order to determine progress and guide necessary insurance
adjustments to monitor and execute vision and strategy for setting and achieving patient
goals (Wei et al., 2018).
The importance of access to health care in order to decrease readmissions cannot
be overemphasized. As a result, hospital administrators are focusing on efforts to improve
the quality of care and reduce spending on readmissions under the provision of the
PPACA (Erdem et al., 2015). This study will use bivariate analysis to infer and evaluate
the statistically significant differences in the variables.
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Significance
This study addressed the research gap concerning insurance coverage and
insurance reimbursement rates associated with readmissions for non-Hispanic Black and
White CHF patients (Levesque, Harris, & Russell, 2015). A significant aspect of this
study is the potential to provide healthcare administrators with information about Black,
non-Hispanic readmission rates in relation to the lack of insurance and access to
healthcare and develop ways to change these outcomes. The Social Cognitive Theory
provided the framework for this study as a construct for understanding how the past may
inform and improve the future (Hoffman, 2016).
Significance for Positive Social Change
The study was designed to examine the differences between hospital readmission
rates and insurance reimbursement rates for non-Hispanic Black and White CHF patients
in California. Even though there is a plethora of research on CHF, there is a gap in the
literature comparing these two populations and whether there needs to be more attention
paid to the reasons Black patients are readmitted more often than White patients
(Boesen, Leal, Sheehan, & Sobolik, 2015; Jeihooni et al.; Levesque, Harris, & Russell,
2015). Black patients have the highest uninsured rates, which consequently increases the
CHF hospital readmission rates (Jeihooni et al., 2016). The high clinical and financial
burden of this condition, especially among young and older adults, has led to an interest
by hospital administrators to improve outcomes and decrease the cost of care (Sharma et
al., 2016).
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Significance for Positive Leadership Change
Furthermore, improving interdisciplinary communication and adopting highreliability principles to achieve safety, better patient outcomes, and improvements in
medical excellence could reduce readmissions in the future. This study could provide
healthcare administrators with information about Blacks, non-Hispanic readmission
utilization rates in relation to the lack of insurance and access to healthcare as compared
to their White counterparts. By improving administrators’ awareness of the differences
and reasons for readmissions, health education programs and strategies could be
developed that would help Black patients and others with CHF learn how to minimize
hospital readmissions and emergency room visits (Sharma et al., 2014; Wagner et al.,
2017, p. 7).
Summary and Conclusions
Many studies in Section 1 demonstrated how important it is for health care leaders
to develop strategies that could decrease hospital readmissions rates. Most readmissions
are a result of chronic conditions and uninsured patients with limited access to healthcare.
CHF is one of the most common chronic diseases, and patients are frequently readmitted
within eight to thirty days after their initial discharge. Studies also focused on creating
healthcare communication systems that encourage staff and patients to develop a better
understanding of health behaviors, financial issues, and insurance coverage as essential
factors that impact hospital readmissions – either positively or negatively. The hospitals
with higher rates of readmissions face reductions in payment and scrutiny from the
insurance companies. Hospital administrators have a responsibility to develop tools and
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methods to reduce readmissions and also to accurately identify high-risk CHF patients
that would benefit from more effective interventions.
Section 1 explored the focus of this study on differences in readmission and
reimbursement rates for non-Hispanic Black and White CHF patients. Many studies were
identified that relate to the problem, purpose, and variables of this study. Next, Section 2
will discuss the research design, data collection, and methodology of this study.
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Section 2: Research Design and Data Collection
Introduction
The purpose of this study was to examine the differences, if any, between nonHispanic Black and White CHF patients concerning hospital readmission rates and
insurance reimbursement rates. Studies have shown that there is no significant follow-up
for Black patients with their primary care physicians after hospital discharge (Betancourt
et al., 2015). Research on causes for CHF readmissions could improve health system
protocols and enhance access to healthcare by encouraging Black patients with CHF to
follow up with their primary care physician after hospital discharge. Involving the
executive leadership team in the patient readmission process using clear metrics allows
healthcare administrators to explore necessary adjustments and execute strategies for
setting and achieving patient goals (Wei et al., 2018).
The importance of access to healthcare is essential for positive health outcomes.
As a result, hospital administrators are focusing on efforts to improve the quality of care
and reduce spending on readmission under the provisions of the PPACA (Erdem et al.,
2014). For this study, I used a t-test analysis to infer the statistically significant
differences between hospital readmission rates and insurance reimbursement rates for
Blacks, non-Hispanic, and Whites, non-Hispanics CHF patients.
Research Design and Rationale
Research Design
A quantitative correlational study involves converting data to a numerical form
that can be subjected to a statistical analysis via SPSS or other programs to investigate
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the relationship between variables (Babbie, 2015, p. 423). Variables are logical sets of
attributes; they are measured using analytical instruments to determine values (FrankfortNachmias & Leon-Guerrero, 2015). The differences between readmission rates and
insurance reimbursement rates for non-Hispanic Black and White CHF patients were the
focus of the statistical examination in this study. In order to determine the relationship
between the independent and dependent variables, I used a correlational design.
Variables
In this study, I analyzed two independent variables and one dependent variable.
The dependent variable for this study was CHF readmission rates for non-Hispanic Black
and White patients in California. The independent variable was insurance reimbursement
rates for non-Hispanic Black and White CHF patients in California. Insurance
reimbursement included an analysis of average private insurance reimbursements,
average uninsured private pay reimbursements, Medicare, and Medicaid. Correlational
research is useful for measuring the strength of a linear relationship (Creswell, 2009). As
part of my correlational analysis, I compared the dependent variable separately with each
of the independent variables to determine the differences.
By using a correlational design and secondary data, I encountered no resource
constraints for this study nor any anticipated delays. The recruitment of participants was
not applicable for data collection purposes. Also, the secondary data set was obtainable
more quickly than primary data, and it provided the basis for data comparison.
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Methodology
In this section, I will cover the population of the study, sampling, the data
collection process, power analysis, sample size estimation, and the data analysis plan.
Population
The target population for this study was non-Hispanic Black and White CHF
patients ages 18-64 living in California. According to Black and Schiller (2015), many
Black patients have limited access to health care and may have no insurance coverage. In
addition, this racial-ethnic group has the highest number of hospital readmissions in the
United States (Basu, Hanchate, & Bierman, 2018). In order to generalize the study
findings, I included in the study group, all possible sampling units that represented the
population, as per Frankfort-Nachmias & Leon-Guerrero (2015).
Sampling and Sampling Procedures
I used probability sampling as the sampling strategy for this study. Probability
sampling was used because of the larger study population. The specific sampling design
for this study was stratified random sampling (Frankfort-Nachmias & Leon-Guerrero,
2015, p. 207). I selected acute care hospitals and emergency room sampling units based
on predetermined parameters that included Black, non-Hispanic and White non-Hispanic
patients. Additionally, the sample population included participants who were private pay,
uninsured, or Medicaid beneficiaries. Probability analysis helps create an accurate
selection of the study population, and researchers can use other statistical methods to
determine the precise sample size (Babbie, 2015).
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I did not consider cluster random or systematic sampling design appropriate for
this study. Cluster random is suitable only when participants are geographically spread
out to other states (Frankfort-Nachmias & Leon-Guerrero, 2015). In this study, I
excluded Black patients with CHF from other states and focused only on Black patients
with CHF in California. Nonprobability sampling designs, such as purposive sampling,
also would not have been appropriate for this study. This is because the sampling units
would have predetermined parameters due to a small sample size that allows all groups to
be inclusive in the survey (see Frankfort-Nachmias & Leon-Guerrero, 2015).
Sample size estimation. I calculated the required sample size estimation using
G*Power software. A t-test was selected, and the correlational point biserial model
statistical test was selected using the G*Power software. A priori power analysis was
conducted to determine the necessary sample size needed to run a correlation analysis
between the variables of CHF readmission rates and insurance reimbursement rates. The
results of the analysis indicated that a sample size of 305 was sufficient to detect a
significant correlation with a medium effect size with a power of .90 and an alpha of .05.
Data Analysis Plan
I obtained the data set used for this study from the OSHPD. The data set is an
aggregated data set collected and coded in Excel. Because of the use of secondary data,
no individual or organization participated in this study. The statistical technique was a ttest, which is the analysis of variance to test for differences between groups.
I downloaded and stored the nonconfidential data set on my hard drive.
Additionally, standard descriptive statistics for each variable were performed. Means,
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standard deviations, and tests of normality for each variable were run using SPSS.
Furthermore, means and standard deviations for each group within the respective
categorical variables were analyzed. The RQs and hypotheses were as follows:
RQ 1. What is the difference, if any, between hospital CHF readmission rates for
Blacks, non-Hispanic and Whites, non-Hispanic in California?
H11: There is a statistically significant difference between hospital CHF
readmission rates for Blacks, non-Hispanic, and Whites, non-Hispanic in
California.
H01: There is not a statistically significant difference between hospital CHF
readmission rates for Blacks, non-Hispanic, and Whites, non-Hispanic in
California.
RQ 2: What is the difference, if any, between hospital CHF readmission insurance
reimbursement for Blacks, non-Hispanic and Whites, non-Hispanic in California?
H12: There is a statistically significant difference between hospital CHF
readmission insurance reimbursement for Blacks, non-Hispanic and Whites, nonHispanic in California.
H02: There is not a statistically significant difference between hospital CHF
readmission insurance reimbursement for Blacks, non-Hispanic and Whites, nonHispanic in California.
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Threats to Validity
External Validity
An essential aspect of this study involved the evaluation of threats to external
validity, which may occur when incorrect inference from sample data is drawn (Creswell,
2009). The threat of interactive effects of experimental arrangement may arise when
results are generalized beyond the racial groups or social groups not included in this
study. Also, OSHPD, the primary data source for this study, collects data from hospitals
that may use different approaches when identifying the readmission process. Some
hospitals have returning CHF patients placed under observation criteria for fear of
readmission penalties, while other hospitals consider returning CHF patients as
readmissions with 30 days. This threat narrows the characteristics of participants in the
study (Creswell, 2009).
Internal Validity
Threats to internal validity pertain to the subjective experiences of the
participants. Participants were selected with certain characteristics that could predispose
them to have certain outcomes. For example, this study used CHF as the only diagnosis.
Access to care and conditions of severity are highly subjective between patients. Internal
validity can be minimized by taking preventive action (Trochim, Donnelly, & Arora,
2016, p. 217).
Ethical Procedures
Patient-specific information was protected and de-identified before being reported
to the Office of Statewide Health Planning and Development, which is the primary source
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of data for this study. Since the data is de-identified, there is no risk associated with the
disclosure of confidential information from the dataset obtained. Anonymity and
confidentiality of the OSHPD data are strictly maintained (Creswell, 2009). A review of
ethical procedures and the protection of human subjects was obtained from the Walden
University Institute Review Board. The dataset for this study was stored on my personal
computer, password-restricted, and secured and was deleted after the research was
completed.
Summary
The purpose of this study was to examine the differences between hospital
readmission rates, and insurance reimbursement rates for Blacks, non-Hispanic and
Whites, non-Hispanic patients with congestive heart failure. In this section, the study
design and rationale were addressed, indicating the population investigated, the source of
data, the data collection procedure, and data analysis strategy and techniques. Also,
threats to validity and ethical methods were discussed. Section two provides the
methodology and research design for this study. Section Three provides a statistical
analysis of the data related to the research questions and hypotheses.
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Section 3: Presentation of the Results and Findings
Introduction
The purpose of this study was to examine the differences between hospital
readmission rates and insurance reimbursement rates for Blacks, non-Hispanic, and
Whites, non-Hispanic with CHF in California. The theoretical framework was Bandura’s
(1986) SCT, which addresses health behaviors and habits. This theory has been used
extensively in healthcare communication as it pertains to the modeling of behaviors and
improvements in processes that could be used to facilitate and improve care for CHF
patients (Pajares et al. 2017). Findings from this study may help healthcare
administrators identify a better approach for providing care to Black, non-Hispanic
patients with CHF to reduce the readmission phenomenon.
I used a correlational design to determine if there were any statistically significant
differences between hospital readmission rates and insurance reimbursement rates for
Black, non-Hispanic CHF patients, and White, non-Hispanic CHF patients. Categories
for reimbursement included average total reimbursements, average Medicare
reimbursements, average Medicaid reimbursements, average private insurance
reimbursements, and average uninsured private pay reimbursements. The primary
correlational tests used for the analyses were the t-test and Levene’s test for equality of
variances.
Research Questions and Hypotheses
RQ 1. What is the difference, if any, between hospital CHF readmission rates for
Blacks, non-Hispanic and Whites, non-Hispanic in California?
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H11: There is a statistically significant difference between hospital CHF
readmission rates for Blacks, non-Hispanic, and Whites, non-Hispanic in
California.
H01: There is not a statistically significant difference between hospital CHF
readmission rates for Blacks, non-Hispanic, and Whites, non-Hispanic in
California.
RQ 2: What is the difference, if any, between hospital CHF readmission insurance
reimbursement for Blacks, non-Hispanic and Whites, non-Hispanic in California?
H12: There is a statistically significant difference between hospital CHF
readmission insurance reimbursement for Blacks, non-Hispanic and Whites, nonHispanic in California.
H02: There is not a statistically significant difference between hospital CHF
readmission insurance reimbursement for Blacks, non-Hispanic and Whites, nonHispanic in California.
Data Collection of Secondary Data Set
Time Frame and Discrepancies of the Data Set
The data collection involved downloading readmission discharge data from the
OSHPD for calendar years 2014-2016 and SID for calendar years 2014-2016 from
HCUP. Using the provider report from CMS, I was able to examine the following
explanatory variables diagnosis-related group (DRG), provider ID, provider zip code,
total discharged, average covered charges, average total reimbursements, average
Medicare reimbursements, average Medicaid reimbursements, and average private

37
insurance reimbursements, average uninsured private pay reimbursements, age (mean),
and break-out. The variables for insurance reimbursement were categorized as follows:
average total reimbursements, average Medicare reimbursements, average Medicaid
reimbursements, average private insurance reimbursements, and average uninsured
private pay reimbursements. The statewide data for calendar years 2014-2016 obtained
from HCUP and OSPHD met the readmission and discharged criteria therefore, the data
collected had no discrepancies. The data presented discharged CHF patients who were
readmitted within 30 days of initial discharge. Thus, the number of CHF discharges for
patients classified as readmitted was used to analyze the differences between readmission
rates and reimbursement rates for Blacks, non-Hispanic, and Whites, non-Hispanic in
California.
Descriptive and Demographic Characteristics of Sample
The data analysis process began after I received Institutional Review Board
approval from Walden University; the approval number is 05-01-19-0649191. All data
files were extracted and downloaded into Excel software. I identified 677 hospitals
statewide in California with progressive CHF readmission discharge. The data obtained
were comprised of the following ethnic groups: Blacks, non-Hispanic, Whites, nonHispanic, Asians, non-Hispanic, and Hispanics.
Table 1 presents the descriptive statistics for ethnicity within the sample. The
sample consisted of the following groups of CHF patients: Blacks, non-Hispanic at 240
(36%); Whites, non-Hispanic at 195 (29%); Asians, non-Hispanic at 84 (12%), and
Hispanics at 110 (16%). My research questions focused on Blacks, non-Hispanic, and
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Whites, non-Hispanic. Asians non-Hispanic and Hispanic populations were included in
the descriptive analysis and in Table 1 to illustrate the composition of the data collection.
The reason for including non-Hispanic Asians, Hispanics, and other ethnic groups in the
descriptive analysis is to show the CHF readmission phenomenon in the State of
California and to highlight the CHF readmission levels with different ethnicities besides
Blacks, non-Hispanic and Whites, non-Hispanic.
Table 1
Descriptive Statistics for Ethnicity
Ethnic group
Hispanic
Non–Hispanic Asian
Non–Hispanic Black
Non–Hispanic White
Other

N
110
84
240
195
46

%
16%
12%
36%
29%
7%

Results
Statistical Assumptions for RQ 1: CHF Readmission Rates
RQ 1. What is the difference, if any, between hospital CHF readmission rates for
Blacks, non-Hispanic and Whites, non-Hispanic in California?
T-Test. I conducted a t-test to test for the difference in mean readmission
discharges for non-Hispanic Black and White CHF patients. I performed the test to
evaluate the assumption of equal variance in each group to determine if they were similar
to each other. I assumed that, if the Levene’s test is significant (p <. 05), then the
variance of the groups would be significantly different from each other, and therefore,
equal variance would not be assumed. However, if the Levene’s test was not statistically

39
significant (p > .05), then the variance would not be significantly different, and then
equal variance would be assumed (see Table 2).
Analysis. The t-test analysis for Figure 1 shows that for this particular analysis,
the assumption of equal variances between the groups was not violated (Levene’s test, F
= .454, p = .501). In this scenario, the analysis for equal variance is assumed and
therefore can be used for these analyses. An independent t-test was conducted to compare
the total number of CHF readmission discharges in Blacks, non-Hispanic and Whites,
non-Hispanic, and the results show that there was not a significant difference between the
average number of readmission discharges for Blacks, non-Hispanic (M = 49.6, SD =
38.28) and Whites, non-Hispanic (M = 50.88, SD = 36.52), t = -.352, p = .725.
Levene's
Test for
Equality of
Variances

t-test for Equality of Means
95% Confidence
Interval of the
Sig. (2-
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Figure 1. Independent samples test for total number of readmission discharges.
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Statistical Assumptions for RQ 2: CHF Readmission Insurance Reimbursement
Rates
RQ 2: What is the difference, if any, between hospital CHF readmission insurance
reimbursement for Blacks, non-Hispanic and Whites, non-Hispanic in California?
Statistical assumptions for all insurance elements. A t-test was conducted to
test for the difference in the average readmission insurance reimbursement rate for nonHispanic Black and White CHF patients. The t-test analysis in Figure 2 shows that for
this particular analysis, the assumption of equal variance between the groups violated
Levene’s Test, (F=4.033, p=.045) therefore the analysis for equal variance is used for the
analysis, however, in this situation, the equal variance is not assumed. An independent ttest conducted to compare the average insurance reimbursement rates for Blacks, nonHispanic and Whites, non-Hispanic, the results showed that the result of the groups are
not significantly different; Blacks, non-Hispanic (M = 9987.82, SD = 4098.29) and NonHispanic Whites (M = 10058.05, SD = 3990.81), t = -.183, p = .855. Therefore, there is
not a statistically significant difference between Blacks, non-Hispanic, and Whites, nonHispanic in readmission insurance reimbursement rates.
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Figure 2. Independent samples test for average total insurance reimbursement rates.

Table 2.
Descriptive Statistics for Average Medicare Payments by Group Variable
Ethnic group
Non-Hispanic Black
Non-Hispanic White

N
240
195

Mean
9127.19
9248.69

SD
4139.30
3869.47

SE
267.19
277.10

Statistical assumptions for Medicare payments. A t-test was conducted to test
for the difference in average readmission Medicare payments reimbursements for nonHispanic Black and White CHF patients. The t-test analysis in Figure 3 shows that for
this particular analysis, the assumption of equal variances between the groups is violated
(Levene’s Test, F = 4.188, p = .041). Thus, the analysis for equal variances not assumed.
An independent t-test was conducted to compare the average Medicare insurance
reimbursement rates for non-Hispanic Black and White CHF patients. There was not a

42
significant difference between the average Medicare reimbursement rates for NonHispanic Blacks (M = 9127.19, SD = 4139.30) and Non-Hispanic Whites (M = 9248.69,
SD = 3869.47), t = -.316, p = .752 who were readmitted with CHF.
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Figure 3. Independent samples test average Medicare reimbursement rates.

Table 3.
Descriptive Statistics for Average Medicaid Payments by Group Variable
Ethic group
Non-Hispanic Black
Non-Hispanic White

N
240
195

Mean
2678.42
2656.82

SD
625.36
636.18

SE
40.37
45.56

Statistical assumptions for Medicaid payments. A t-test was conducted to test
for the difference in average readmission Medicaid reimbursement rates for non-Hispanic
Black and White CHF patients. The t-test analysis in Figure 4 shows that for this
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particular analysis, the assumption of equal variances between the groups is not violated
(Levene’s Test, F = .126, p = .722). Thus, the analysis of equal variances is assumed. An
independent t-test was conducted to compare the average Medicaid reimbursement rates
for non-Hispanic Black and White CHF patients. There was not a significant difference
between the average Medicaid reimbursement rates for Non-Hispanic Blacks (M =
9127.19, SD = 4139.30) and Non-Hispanic Whites (M = 9248.69, SD = 3869.47), t =
.356, p = .722 who were readmitted with CHF.
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Figure 4. Independent samples test average for Medicaid reimbursement rates.

Table 4.
Descriptive Statistics for Average Private Insurance Payments by Group Variable
Ethic group
Non-Hispanic Black
Non-Hispanic White

N
240
195

Mean
1381.90
1384.90

SD
224.84
218.48

SE
14.51
15.65
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Statistical assumptions for private insurance payment. A t-test was conducted
to test for the differences in average private payment reimbursement rates for Blacks,
non-Hispanic, and Whites, non-Hispanic. The t-test analysis in Figure 5 shows that for
this particular analysis, the assumption of equal variances between the groups is not
violated (Levene’s Test, F = .031, p = .86). Thus, the analysis of equal variances is
assumed. An independent t-test was conducted to compare the average private insurance
reimbursement rates for non-Hispanic Black and White CHF patients. There was not a
significant difference between the average private insurance reimbursement rates for nonHispanic Blacks (M =1381.90, SD = 224.84) and non-Hispanic Whites (M = 1384.90, SD
= 218.48), t = -.14, p = .89 who were readmitted with CHF.
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Figure 5. Independent samples test average for private reimbursement rates.
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Table 5.
Descriptive Statistics for Uninsured Private Payments by Group Variable
Ethic group
Non-Hispanic Black
Non-Hispanic White

N
240
195

Mean
635.21
652.77

SD
331.52
328.33

SE
21.40
23.51

Statistical assumptions for uninsured private payments. A t-test was
conducted to test for the difference in average readmission uninsured private payment
reimbursement for non-Hispanic Black and White CHF patients. The t-test analysis for
Figure 6 shows that for this particular analysis, the assumption of equal variances
between the groups is not violated (Levene’s Test, F = .701, p = .403). Thus, the analysis
for equal variances assumed. An independent t-test was conducted to compare the
average of uninsured private payment reimbursement rates for non-Hispanic Black and
White CHF patients. There was not a significant difference between the average
uninsured private payment reimbursement rates for Blacks, non-Hispanic (M =635.21,
SD = 331.52) and Whites, non-Hispanic (M = 652.77, SD = 328.33), t = -.552, p = .58
who were readmitted with CHF.
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Figure 6. Independent samples test average for uninsured reimbursement rates.

Results for Research Question 1
RQ 1 concerned whether there were significant differences in readmission rates
for non-Hispanic Black and White CHF patients. Based on the analysis conducted, the
results indicated that even though Black, non-Hispanic readmission rates were N =240 as
compared to Whites, non-Hispanic N =195, there was not a statistically significant
difference in the readmission rates.
Hypothesis acceptance for RQ 1. As a result of the analyses using the t-test and
Levene’s Test for Equality of Variances, the null hypothesis was accepted, which stated
that there is not a statistically significant difference between hospital readmission rates
for Blacks, non-Hispanic, and Whites, non-Hispanic readmitted with CHF in California.
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Results for Research Question 2
RQ 2 addressed concerns about whether there were significant differences in
insurance reimbursement rates. All-payer types were analyzed, and they included:
Medicare, Medicaid, private insurance reimbursement, and uninsured private payment
reimbursement.
Medicare. The results indicated that for average Medicare reimbursement rates
there was not a statistically significant difference between the average Medicare
reimbursement rates for non-Hispanic Blacks (M = 9127.19, SD = 4139.30) and nonHispanic Whites (M = 9248.69, SD = 3869.47), t = -.316, p = .752.
Medicaid. The results indicated that for average Medicaid reimbursement rates
there was not a statistically significant difference between the average Medicaid
reimbursement rates for non-Hispanic Blacks (M = 9127.19, SD = 4139.30) and nonHispanic Whites (M = 9248.69, SD = 3869.47), t = .356, p = .722.
Private insurance reimbursement. The results indicated that for average private
insurance reimbursement rates there was not a statistically significant difference between
the average private payment reimbursement rates for non-Hispanic Blacks (M =1381.90,
SD = 224.84) and non-Hispanic Whites (M = 1384.90, SD = 218.48), t = -.14, p = .89.
Uninsured private payment reimbursement. The results indicated that for
average uninsured reimbursement rates there was not a statistically significant difference
between the average uninsured private payment reimbursement rates for Non-Hispanic
Blacks (M =635.21, SD = 331.52) and Non-Hispanic Whites (M = 652.77, SD = 328.33),
t = -.552, p = .58.
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Hypothesis acceptance for RQ 2. As a result of the analyses for these payment
types consisting of a t-test and Levene’s Test for Equality of Variances the results
indicated that the null hypothesis was accepted which stated that there is not a statistically
significant difference between hospital reimbursement rates for Blacks, non-Hispanic,
and Whites, non-Hispanic readmitted with CHF in California.
Summary
The purpose of this study was to examine the correlation between hospital
readmission rates, and reimbursement rates for Blacks, non- Hispanic and Whites, nonHispanic with congestive heart failure in California. In Section 3 secondary data from the
Office of Statewide Health Planning and Development (OSHPD) for calendar years
2014- 2016 and State Inpatient Databases (SID) for calendar years 2014- 2016 from
Healthcare Cost and Utilization Project (HCUP) were analyzed using the t-test and
Levene’s Test for Equality of Variances. Based on the hospital CHF readmission
discharge rates, the results of the analyses indicated that there were no significant
differences between non-Hispanic Black and White CHF patients concerning readmission
rates and reimbursement rates.
In Section 4, the interpretation of findings and limitations of the study will be
further examined. Bandura’s Social Cognitive Theory is the framework for this research,
and the results of this study will be addressed concerning positive health behaviors. This
section will also discuss the recommendations for future research and the implication of
professional practice and social change as specified by the purpose of this study.
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Section 4: Application to Professional Practice and Implications for Social Change
Introduction
The purpose of this study was to examine the differences between hospital
readmission rates and insurance reimbursement rates for non-Hispanic Black and White
patients with CHF who live in California. I obtained the secondary data for this study
from the OSHPD for calendar years 2014-2016 and SID for calendar years 2014-2016
from HCUP. Statistical analyses were performed using a t-test, along with Levene’s test
for equality of variances. The findings of the t-test indicated no significant differences
between readmission rates and insurance reimbursement rates for Blacks, non-Hispanic,
and Whites, non-Hispanic.
In addition to the t-tests, I conducted a descriptive analysis of the population for
each variable. I used SPSS software for data analyses and did not report values less than
10, as per HCUP SID reporting guidelines (HCUP SID, 2018). Bandura’s (1987) SCT,
which was the framework of this study, has as a tenet that personal efficacy has an impact
on how one can reinforce or carry out personal changes. I surmised that this central belief
of change would be the fundamental factor to motivate Blacks, non-Hispanic, to take
action to improve health behaviors. Section 4 includes an interpretation of the findings,
discussion of limitations of the study, recommendations for further research, and
consideration of the study’s implications for professional practice and social change.
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Interpretation of the Findings
RQ 1: CHF Readmission Rates
I conducted an independent t-test to compare the total number of CHF
readmission discharges for Blacks, non-Hispanic and Whites, non-Hispanic. The results
indicated that there is not a statistically significant difference between the average
number of readmission discharges for Blacks, non-Hispanic (M = 49.6, SD = 38.28) and
Whites, non-Hispanic (M =50.88, SD = 36.52), t = -.352, p = .725. The test results exceed
the p-value of 5%; therefore, the null hypothesis, which stated that there is not a
statistically significant difference between hospital CHF readmission rates for Blacks,
non-Hispanic, and Whites, non-Hispanic in California, is accepted.
Even though readmission rates for Blacks (36%) were higher than those for
Whites (29%) based on the data obtained from OSHPD and HCUP, there was not a
statistically significant difference. Since the p-value is .725, healthcare administrators
would not reasonably use this study as a basis for determining if hospital readmission
rates for Blacks, non-Hispanic are different than those of Whites, non-Hispanic.
However, the research related to this study has shown the importance of developing
programs that link hospitals, CHF patients, and providers to partners and establishing
protocols and communication to improve outcomes and reduce readmissions
(Chamberlain, Sond, Mahendraraj, Lau, & Siracuse, 2018). Developing these programs is
appropriate and necessary because CHF patients experience care in numerous settings,
including primary care, inpatient, and post-acute. The goal is to minimize readmissions,
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as emphasized in the one million hearts campaign designed by CMS and Centers for
Disease Control and Prevention (Sanghavi et al., 2015).
RQ 2: Insurance Reimbursement Rates (All-Payer Types) for CHF Readmissions
I conducted an independent t-test analysis to compare the differences between the
average reimbursement rates, and the results indicated for Medicare reimbursement rates
between Blacks, non-Hispanic and Whites, non-Hispanic there was not a statistically
significant difference. The average reimbursement rates for Medicare were analyzed, and
the results indicated that there was not a statistically significant difference between the
average Medicare reimbursement rates for non-Hispanic Blacks (M = 9127.19, SD =
4139.30) and non-Hispanic Whites (M = 9248.69, SD = 3869.47), t = -.316, p = .752. The
test results exceed the p-value of 5%, indicating there is no likelihood that there are
differences in average Medicare readmission reimbursement rates.
Second, an independent t-test analysis was conducted to examine the average
Medicaid reimbursement rates, the results indicated that there was not a significant
difference between the average Medicaid reimbursement rates for non-Hispanic Blacks
(M = 9127.19, SD = 4139.30) and non-Hispanic Whites (M = 9248.69, SD = 3869.47), t =
.356, p = .722. The test results exceed the p-value of 5%, further indicating there is no
likelihood that there are differences in average Medicaid readmission reimbursement
rates.
Thirdly, an independent t-test analysis was conducted to examine the average
private insurance reimbursement rates. The results indicated that there was not a
significant difference between the average private payment reimbursement rates for non-
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Hispanic Blacks (M =1381.90, SD = 224.84) and non-Hispanic Whites (M = 1384.90, SD
= 218.48), t = -.14, p = .89. The test results exceed the p-value of 5%, indicating there is
no likelihood that there are differences in average private insurance readmission
reimbursement rates.
Lastly, an independent t-test analysis was conducted to examine the average
uninsured private pay reimbursement rates. The results indicated that there was not a
significant difference between the average uninsured private pay reimbursement rates for
Blacks, non-Hispanic (M =635.21, SD = 331.52) and Whites, non-Hispanic (M = 652.77,
SD = 328.33), t = -.552, p = .58. The test results exceed the p-value of 5%, indicating
there is no likelihood that there are differences in average uninsured private pay
readmission reimbursement rates. Therefore, the null hypothesis was accepted, which
stated that there is not a statistically significant difference between hospital CHF
reimbursement for Blacks, non-Hispanic, and Whites, non-Hispanic in California.
General Discussion
CHF accounts for one million hospitalizations annually (Basu et al., 2018).
According to Piamjariyakul et al. (2015), the excessive financial burden associated with
CHF readmissions and many other chronic conditions is driven by the disintegrated and
uncoordinated health system. Reducing readmissions not only reduces health care
expenditures but also importantly improves patient outcomes (Chamberlain et al., 2018).
This study contributes to current research by highlighting the readmission and
reimbursement patterns of non-Hispanic Black and White CHF patients in California.
The Hospital Readmission Reduction Program (HRRP) was established as part of the

53
PPACA to provide a financial incentive to hospitals to engage in quality improvement
efforts to reduce readmission (Kulaylat, Jung, Hollenbeak, & Messaris, 2018). This
program levied penalties on hospitals with higher-than-normal readmission rates. The
goal of this program was to link payment with the quality of care to minimize the
disparity between hospitals and reduce readmission (Bergethon et al., 2017).
Findings in Relation to Theoretical Framework
Drawing from the theoretical framework of this study, SCT (Bandura, 1997),
beliefs of personal efficacy have an impact on how one can enforce or carry out personal
changes. This central belief of change is the fundamental factor to motivate Blacks, nonHispanic, to take action to improve health behaviors (D’Angelo & Lawson, 2018). The
SCT indicates that behaviors are regulated by social approval and disapproval, and
consequently, this behavior allows people to adapt to personal principles and adjust their
behavioral patterns by self-evaluation, which will enable them to do activities purposely
to gain self-satisfaction (Jeihooni et al., 2016).
SCT relates to this study because beliefs influence purposes and aspirations (see
Cherry, 2019). If one’s perceived self-efficacy is stronger, then there are tendencies that
one would set higher goals and commit to those goals (Jeihooni et al., 2016). The
personal change would be easy if there were no impediments to surmount. Self-efficacy
belief must be measured against the challenges to accomplish change. For example, for a
CHF patient to acknowledge lifestyle changes and compliance with an exercise routine,
the CHF patient needs to judge self-efficacy in order to accomplish these exercise goals
under stressful circumstances and obstacles. If there are no impediments to surmount,
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then the goals will be attained. Self-efficacy beliefs shape outcomes (Cherry, 2019).
Accepting and redefining healthy choices paves the way for better results. According to
Sanghavi et al. (2016), it is estimated that behavior accounts for 80% cardiovascular
disease. Non-Hispanic Blacks face unique challenges to adhere to dietary and exercise
recommendations as compared to their White counterparts; as a result, there is a high
propensity of readmission rates for Blacks, non-Hispanic (Carnethon et al., 2017).
Limitations of the Study
The study methodology has provided the strength for this study; a t-test analysis
was conducted to test for the differences between hospital readmission and insurance
reimbursement for Black, non-Hispanic and White, non-Hispanic patients with CHF in
California. In this study, several limitations were identified: firstly, the differences in
insurance reimbursement rates between these ethnic groups and hospital readmissions.
The rising health cost and increasing disparity in the quality of healthcare have spurred
payment reform initiatives. Secondly, reliance on billing codes for identification of CHF
and cardiovascular diseases may result in misclassification. Thirdly, the HCUP data
2014-2016 indicated that not all statewide inpatient data files contain American Heart
Association linkage data elements; therefore, the data linkage in this study might have
some few discrepancies providing a variance between the Blacks, non-Hispanic and
Whites, non-Hispanic. Thirdly, in this study context, the population is not reflective of
racial/ethnic distribution of the United States population. Finally, the recording of
demographic information, including race and ethnicity, during the admission registration
process may not be entered correctly, and this creates data reliability issues.
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Recommendations
Non-Hispanic Blacks in this study have a readmission rate of 36%, and Whites,
non-Hispanic have a readmission rate of 29%. The t-test analytic results indicated that the
differences are not statistically significant even though Blacks, non-Hispanic have the
highest risk of heart failure as compared to their White counterparts. The prominence of
disparities in the onset of CHF at a younger age highlights cardiovascular risk and an
increased rate of readmissions (Carnethon et al., 2017). Differences in heart failure
management are a significant drawback (Fonarrow, Konstam, & Yancy, 2017). Further
research is needed to expand on the trend of readmission rates for non-Hispanic Black
and White CHF patients compared to other racial/ethnic groups in California. Secondly,
further research is needed to expand on the appropriateness of insurance reimbursement
rates for average Medicare reimbursement, average Medicaid reimbursement, average
private insurance reimbursement, and average uninsured private pay reimbursement rates
for CHF readmissions to determine discrepancies related to racial/ethnic groups.
Implications for Professional Practice and Positive Social Change
As part of the Patient Protection and Affordable Care Act, significant reforms
have been enacted to improve health care outcomes and quality of care to prevent
hospital rehospitalization and decreased health care costs (Boesen, Leal, Sheehan, &
Sobolik, 2015, p. 237). Boesen et al., (2015) indicated that the CMS reported that
improving health insurance status, access to care, and quality of care for racial minority
groups reduces rehospitalization. Studies have shown that such quality of care entails
ensuring that (i) the patient is clinically ready for discharge (ii) communication with
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health care providers improves and enhances patient education and (iii) resources that
affect the optimal management of CHF are provided. The subsequent paragraphs expand
on the implications for professional practice and positive social change.
Professional Practice
According to Piamjariyakul et al. (2015), financial assessments and referrals to
social services are crucial for assistance with patients’ expenses and cost of care to
prevent rehospitalization and improve health outcomes. Strategies to prevent CHF and
improve efficiency can be optimized if patients have more opportunities to participate in
the management of their care. According to Kulaylat et al. (2018), racial differences
exist and affect care utilization; however, health care administrators can develop new
ways to approach health care to eliminate racial/ethnic disparities and promote patientcentered care. Boustani et al. (2019), discussed the need to develop Agile
Implementations (AI) as a way to use evidence-based services in their organizations. By
identifying opportunities and developing processes that focus on system improvements,
care for all patients can be improved. Over the next generation, CHF will continue to
increase if current approaches to care are not improved (Bergethon et al., 2017).
Healthy People 2030 Framework, published in June of 2018, presented similar views
toward changing the current method of providing health care to the American people. The
focus of the Healthy People 2030 Framework is improving health care for the American
people, through a healthy heart-healthy family approach. This cardiovascular information
provides education aimed at promoting improvements in heart care by sharing evidencebased data from a diverse group of health professionals (Healthy People 2030, 2018).
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Positive Social Change
Congestive heart failure is a substantial health burden in the United States,
affecting 5.7 million at an annual cost of 30.7 billion (Boesen et al., 2015). This study
indicated that non-Hispanic Blacks had the highest readmission rate of 36% as opposed
to 29% for non-Hispanic Whites. Identifying an organization’s internal strengths and
weaknesses is a challenging yet essential aspect of health care organizations to combat
hospital readmission and improve insurance reimbursement rates for racial/ethnic groups.
A critical component of strategic momentum is pointed out by Chamberlain et al.
(2018) through evaluation of the organization’s strengths and weaknesses relative to the
environment, such as ethnic/racial diversity, aging population, regulatory changes, and
the growing use of technology. The study supports the purpose of this research
concerning the need to decrease ethnic disparities for non-Hispanic Black CHF patients
in order to reduce readmissions. This research will add to positive social change through
the recognition and emphasis on the need to educate and care for all CHF patients
according to their health needs and based on their unique characteristics (Chamberlain et
al., 2018).
Conclusion
Readmission is a significant concern for hospital administrators and health care
providers. I conducted a t-test to examine the differences between hospital readmission
and insurance reimbursement rates for non-Hispanic Black and White patients with CHF
in California. The results of the t-test analysis indicated that first, there was not a
statistically significant difference in hospital readmission rates between these two ethnic
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groups. I also conducted a t-test to examine the differences between insurance
reimbursements rates. The results of the analysis indicated that there was not a
statistically significant difference between insurance reimbursement rates for these ethnic
groups. Knowing that there is a disproportion in financial allocation, further research is
required to better understand the mechanisms behind higher readmission rates for Blacks,
non-Hispanic.
This study addressed the gap in the literature regarding the differences between
hospital readmission and insurance reimbursement rates for non-Hispanic Black and
White patients with CHF in California. Knowing that there is no significant difference
between these ethnic groups, health care providers can focus on methods to reduce CHF
readmissions with programs that link hospitals, CHF patients, and providers to partner
and establish protocols and communication to improve outcomes. The results of this
study contribute to positive social change by providing information that healthcare
professionals may be able to use to decrease CHF readmissions and improve access to
care for non-Hispanic Blacks and other vulnerable groups.
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